In a previous report (1) were described the results of experiments in which isotopic uric acid was injected intravenously into normal and gouty human male subjects. The purpose was to ascertain the magnitude of the "miscible pool," that quantity of uric acid present in the body capable of prompt mixing with the injected material, and the rate of its turnover. The results indicated that there are some 1200 mg. of miscible uric acid normally present, a finding in accord with that of Geren and associates (2) , that between 50 and 75% of this is each day replaced by newly formed uric acid and that this latter quantity exceeds the quantity excreted daily in the urine, suggesting the occurrence of limited catabolism of uric acid in man. In the gouty subjects studied, the magnitude of this miscible pool exceeded the normal levels by as much as 15 fold. Indeed, so large was the quantity of promptly miscible uric acid as to indicate that at least a portion of this material must reside in the solid phase rather than in solution in body fluids.
(Submitted for publication May 15, 1950; accepted, May 22, 1950) In a previous report (1) were described the results of experiments in which isotopic uric acid was injected intravenously into normal and gouty human male subjects. The purpose was to ascertain the magnitude of the "miscible pool," that quantity of uric acid present in the body capable of prompt mixing with the injected material, and the rate of its turnover. The results indicated that there are some 1200 mg. of miscible uric acid normally present, a finding in accord with that of Geren and associates (2) , that between 50 and 75% of this is each day replaced by newly formed uric acid and that this latter quantity exceeds the quantity excreted daily in the urine, suggesting the occurrence of limited catabolism of uric acid in man. In the gouty subjects studied, the magnitude of this miscible pool exceeded the normal levels by as much as 15 fold. Indeed, so large was the quantity of promptly miscible uric acid as to indicate that at least a portion of this material must reside in the solid phase rather than in solution in body fluids.
In the present study 2 we have extended our observations on the amount and distribution of miscible uric acid in the gouty patient and have investigated the effects upon these quantities of some of the therapeutic agents commonly employed in this disease. The effect of ACTH 3 on the normal subject has also been studied.
MATERIALS AND METHODS
The preparation of isotopic uric acid labeled in the one and three positions with N', the isolation of uric acid 1This study was aided in part by grants from the Division of Endocrinology, the United States Public Health Service, and Armour and Co. 2 preliminary report of this work has appeared (3) . 8We are indebted to Dr. John R. Mote, Medical Director, the Armour Laboratories, Chicago, for the ACTH used in these studies.
from the urine samples and isotope analysis have all previously been described (1) . The only novel chemical procedure was the analysis of a tophus excised from subject A. L. on the ninth day of his third experiment. This specimen when dried in vacuo over P205 weighed 6.8 gm.
In the expectation of dissolving successive laminae of uric acid, the tophus was then placed in the thimble of a Soxhlet apparatus over boiling water and extracted for three periods of 24 hours each, the contents of the flask being replaced by fresh water after each period. An aliquot of each extract was analyzed for uric acid by the method of Forsham and co-workers (4) and pure uric acid was isolated from the remaining extract for isotope analysis by the same method previously employed in the isolation from urine (1) . The residue of the tophus was boiled in 500 ml. of 0.07 M Li2COa for one hour, the solution filtered, and analyzed for uric acid. The same mathematical treatment of results has been employed as was described in the earlier report (1) .
Both the normal and gouty subjects were maintained in slightly positive nitrogen balance on constant diets calculated to contain purines equivalent to 2.4 to 3.1 mg. of uric acid per day. It was found that a preliminary period of at least three days on this diet was required to achieve a reasonably constant urinary uric acid output. Sterile solutions of the lithium salt of isotopic uric acid were prepared and injected intravenously as previously described (1) . The injection was carried out over a period of 30 minutes and the midpoint was taken as zero time in the subsequent calculations.
The total urine output of each subject was collected in 12 hour portions, and each sample was analyzed for uric acid by the method of Forsham and colleagues (4) . From In the winter of 1937 he experienced his second attack of joint pain, accompanied by swelling and redness, this time of the right knee. A diagnosis of gout was made at an outside hospital. The patient was placed on a low purine diet which he has followed ever since.
From 1937 to 1940 there were many and frequent attacks of arthralgia, each one lasting for from one to two weeks. Deposits began to develop around the joints and by 1940 motion of practically all the joints of the extremities was severely limited.
From 1940 on the pain was only rarely acute, but there was constant joint ache and impaired mobility; the patient was reduced to a state of chronic invalidism.
Approximately five months before his second admission he was again seen at an outside hospital where he was placed on a regimen of aspirin 4.8 gm. to be taken every third to fourth day.
Outside of the history of high purine intake, there was nothing of significance in the patient's past history. There was no familial background of gout or any other joint disease.
Second admission, Feb. 4, 1949-Physical examination revealed a well nourished (wt. 75 kg.) alert and pleasant man. Firm subcutaneous deposits could be plainly seen and felt around both first metatarso-phalangeal joints, over the patellae and around several of the finger joints ( Figure 1 ). Over the olecranon areas, on both sides, there were well healed scars at the sites where large tophaceous deposits had been excised at another hospital. A toe removed at this admission showed a massive tophus (Figure 2) .
X-ray studies showed many areas of cystic destruction of the bones characteristic of gout. Blood and urine-
FIG. 2. A. L. CROSS SECTION OF THE PATIENT'S LEFT
FIRST METATARSAL The bone has been destroyed by a large tophus. studies were normal except for a slight normocytic anemia (hematocrit 38%) and a serum uric acid of 10 mg. %o.
Maximum urea clearance was 135 %0 of normal and PSP excretion was normal at 32% in 15 minutes and 70% in two hours. The blood urea nitrogen was 19 mg. % on admission, later fell to 11 mg. % on two occasions. It was never found to be elevated during later admissions.
The first experiment with isotopic uric acid was carried out during this admission with the patient on a purine-low diet. Thereafter the patient received a six day course of ACTH (40 mg./day) with good clinical improvement associated with a transitory increase in uric acid excretion ( Figure 3 ) and a fall in serum uric acid from 10.1 to 5.3 mg. %.
The patient was discharged on a purine-low diet and was told to take aspirin and colchicine as needed. This he did only infrequently, since he had a feeling that they helped him very little (Table I) . Two or three days after discharge, the patient experienced one of his rare acute gouty attacks involving the right first metatarsal joint and leading to a discharge of gouty matter through a break in the skin resulting in secondary infection which was treated conservatively.
One month prior to his fourth admission the patient stopped all salicylate and colchicine medication (Table  I) * The size of the miscible pool of uric acid in this subject has been determined on three occasions by the measurement of the dilution of isotope which results when isotopic uric acid is injected intravenously. tient received medication inconstantly and during the last month of this period no medication was taken (Table I) . At the time of the second experiment, the miscible pool had increased to a value of 31,000 mg., almost twice the earlier value or approximately 30 times normal. It is noteworthy that this increase was not accompanied by any significant change in the serum uric acid concentration (last column, Table II ). The figures in the next to the last column represent the mean concentrations of uric acid throughout total body water calculated on the assumptions that all the uric acid in the pool is uniformly distributed throughout all the water of the body (0.7 x body weight). In the normal subjects, such a calculation gave values of approximately half the serum uric acid concentrations. In the untreated gouty subject, this value is far above the serum level, in the present instance far above the expected solubility of uric acid in saturated physiological solution. In the normal subject it was concluded that miscible uric acid is present in some body fluids in concentrations far lower than in plasma, whereas in the gouty subject a large reservoir of miscible uric acid must be postulated, and in view of its size and the relative insolubility of uric acid in physiological solutions, the bulk of this reservoir would appear to be in the solid phase.
During the three months which intervened between the second and third experiments, the patient received aspirin, 2.6-4.0 gm. daily, and although continuous analytical data are not available, spot-checking revealed a urinary excretion of uric acid of approximately 300 mg./day over this subject's basal excretory level. At the time of the third experiment, his miscible pool of uric acid had contracted to about 2000 mg., about onefifteenth of its previous value and about twice the normal value. This dramatic response to therapy was not accompanied by any significant fall in the serum uric acid concentration. It should be noted that there was no clinically obvious diminution in the mass of palpable and visible tophi during this interval. As a consequence of this contracture of the miscible pool, when the mean distribution of miscible uric acid throughout body water was computed, a concentration lower than that in the serum was found just as in the normal subjects.
On the ninth day of the same experiment, a Figure 6 are given the results of this experiment in which ACTH was given during the course of an isotope study. The rise in urinary uric acid excretion as well as the fall in serum uric acid is in every way comparable with that previously noted in the gouty subject. The absence of any change in the rate of decline of the isotope values following the administration of ACTH in this subject is clear evidence that no great increase in the rate of uric acid production had occurred. Such an increase might have been masked by the large size of the pool in experiment A. L.-2, but in the present experiment, where the pool size was quite small (Table IV) an increase in uric acid production sufficient to account for the uric acid diuresis should have been obvious. These results therefore strongly support the view that ACTH operates predominantly at a renal level and they conform with the views and findings of others (5) (6) (7) (8) as to the mode of action of ACTH and corticoids upon uric acid and explain in part the mechanism of ACTH in the treatment of gout (9) (10) (11) (12) .
In the course of the third experiment, subject A. L. was given 1.2 mg. of colchicine every six hours for two successive days without developing signs of toxicity. No significant change in daily urinary excretion of uric acid or in its concentration in serum was detected ( Figure 5 ) nor did any change in the slope of the isotope data occur. Whereas Bishop and associates ( 13) have reported a contracture of the miscible pool of uric acid in response to colchicine in two out of three gouty patients, it should be noted that the subjects in which this effect was described had received no previous medication.
When uric acid labeled with N1' was previously injected, small though significant concentrations of N15 were found in certain samples of urinary urea and ammonia (1) . In the present series we have again noted the appearance of N15 in urea and ammonia following the injection of uric acid labeled with N'5 ( Table V) . This is taken to mean that to a limited extent uric acid is catabolized in man. The finding of Geren and colleagues (2) that oral administration of similarly labeled uric acid resulted in the appearance of an abundance of isotope in urea and ammonia suggests that the intestinal flora rather than the tissues of the host proper may be responsible for this degradation of uric acid.
DISCUSSION
The wide differences in the quantity of uric acid in the "miscible pool" observed when normal and gouty subjects are contrasted and when the same gouty subject is observed prior and subsequent to * Isotopic uric acid has been injected into a normal man, and during the succeeding period the isotope concentration of his urinary uric acid was followed. ACTH was administered for two days during this period (Cf. Figure 6 ). Figure 2) . no longer in contact with body water, are incapable of resolution and are excluded from the miscible pool. The role of salicylates as prophylactic agents in the control of gout may be inferred from the foregoing discussion. They may fail to prevent the appearance of acute gouty arthritis and indeed Gutman (14) has observed the occurrence of such acute attacks during a course of treatment with salicylates which was effectively increasing uric acid excretion. The continuous administration of salicylates may however be expected to inhibit the growth of tophaceous desposits.
SUMMARY
The magnitude of the "miscible pool" of uric acid in a patient suffering from severe chronic tophaceous gout has been determined by measurement of the dilution of isotope which occurred when uric acid labeled with N15 was injected intravenously. This pool, which increased to a value of about 31 gm., or about 30 times normal, fell to a value of about 2 gm., or approximately twice normal when the uricosuric doses of acetylsalicylic acid were given.
The effect of ACTH upon uric acid metabolism has been studied in both gouty and the normal male subjects. The resultant uricosuria appears to arise exclusively from an increased renal clearance of uric acid. Colchicine had no demonstrable effect upon the quantities measured.
It has proved feasible to divide miscible uric acid into three compartments: 1) In solution in plasma water; 2) In solution in non-plasma body water; 3) In the solid phase. It is predominantly the uric acid in the last of these compartments that is subject to wide excursions in response to therapy.
